Dermata Therapeutics (DRMA) Preferred Shares (2020 - 2021)

Dermata Therapeutics (DRMA) posted quarterly Preferred Shares of $691.0 for Q2 2021, down 99.99% quarter-over-quarter from $6.8 million in Q4 2020.

Dermata Therapeutics (DRMA) Preferred Shares (2020 - 2021) Analysis & Trends

Dermata Therapeutics' Preferred Shares history runs 2 years deep, the most recent figure standing at $691.0 for Q2 2021.

In Q2 2021, Preferred Shares changed N/A year-over-year to $691.0; the TTM figure through Jun 2021 stood at $691.0 (changed N/A YoY), while the FY2020 annual figure was $6.8 million, changed N/A from the prior year.
Preferred Shares for Q2 2021 stood at $691.0, down from $6.8 million in the prior quarter.
The five-year high for Preferred Shares was $6.8 million in Q4 2020, with the low at $691.0 in Q2 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	140.52 Bn	132.67 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.54 Bn	78.55 Bn	3.93 Bn	-
3	Argenx Se	65.31 Bn	60.13 Bn	1.37 Bn	-
4	Moderna	61.77 Bn	56.64 Bn	52.00 Mn	-
5	BeOne Medicines	42.26 Bn	37.16 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.19 Bn	27.88 Bn	992.69 Mn	-
7	BioNTech SE	28.71 Bn	10.31 Bn	668.28 Mn	-
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
9	Royalty Pharma	27.35 Bn	26.52 Bn	-	-
10	Dermata Therapeutics	5.52 Mn	5.52 Mn	-	-

Download Data

Date	Value
Jun 30, 2021	691.00
Dec 31, 2020	6.83 Mn